Evotec AG EVO
1.56
0.03
1.96%
as of 25 Sep
- Market cap
- $539.9M
- P/E
- 0.0×
Follow EVO
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | 1.03 | 1.23 | 1.55 | |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
— | (193.71) | 14.64 | (16.30) | |
P/B ratio |
— | 1.08 | 1.19 | 1.38 | |
Price to Tangible BV |
— | 1.92 | 1.90 | 2.21 | |
EV/Sales |
— | 0.97 | 1.19 | 1.91 | |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
— | 45.06 | (102.32) | (416.12) | |
EV/FCF |
— | (12.99) | (10.25) | (14.82) | |
Quick Ratio |
1.92 | 1.36 | 1.77 | 1.01 | |
Current Ratio |
2.33 | 1.68 | 2.07 | 2.12 | |
Net Debt/EBITDA |
0.00 | 1.20 | (0.76) | (3.38) | |
Debt/Assets |
30.23% | 18.22% | 26.18% | 21.87% | |
Debt/Equity |
0.72 | 0.43 | 0.55 | 0.48 | |
Asset Turnover |
0.00 | 0.44 | 0.45 | 0.39 | |
Operating CF/Net income |
0.00 | 0.03 | 4.71 | 1.57 | |
Capex/Depreciation |
0.00 | 0.00 | (0.13) | 0.00 | |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | 6.44% | 3.93% | 5.32% | |
Selling, General and Administrative Expense of Revenue |
— | 27.95% | 17.66% | 25.82% | |
Intangible Assets out of Total Assets |
0.19 | 0.19 | 0.18 | 0.17 | |
Share Based Compensation of Revenue |
— | 0.00% | 1.45% | 0.00% | |
Graham Net Nets |
— | (0.30) | (0.14) | (0.16) | |
Graham Number |
— | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
— | (25.52%) | (10.71%) | (13.73%) | |
Free Cash Flow Yield |
— | (7.25%) | (9.47%) | (8.30%) | |
Revenue per Share |
— | 0.52 | 0.83 | 0.54 | |
Operating CF per Share |
0.00 | (0.01) | 0.21 | (0.22) | |
Capex per Share |
0.00 | (0.04) | (0.04) | (0.07) | |
Free Cash Flow per Share |
0.00 | (0.05) | 0.17 | (0.30) | |
Cash per Share |
0.00 | 1.47 | 1.52 | 0.78 | |
Shareholders Equity per Share |
0.00 | 2.31 | 2.59 | 2.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 2.31 | 2.59 | 2.63 | |
Free Cash Flow |
(137.31) | (17.11) | 59.89 | (105.70) | |
Working Capital |
484.18 | 336.96 | 446.76 | 489.36 | |
Capital Expenditures |
(12.71) | (12.53) | (14.83) | (26.56) | |
Net Current Asset Value |
(208.71) | (267.92) | (155.34) | (209.76) | |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.07 | 0.05 | 0.14 | |
Net Profit Margin |
— | (77.84%) | 5.37% | (26.29%) | |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
145.38 | 181.83 | 184.26 | 227.35 | |
Average Payables |
61.47 | 64.42 | 83.05 | 67.35 | |
Average Inventory |
42.04 | 36.95 | 33.42 | 37.89 | |
Average Assets |
1,941.40 | 1,984.10 | 2,004.34 | 2,130.60 | |
Average Common Equity |
867.00 | 889.89 | 975.68 | 1,000.10 |
Columns are period end dates